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INTRODUCTION
Visual Molecular Dynamics (VMD) computer modeling is a readily available, intuitive and powerful tool for studying complex molecular interactions such as protein aggregation and its effect on protein activity and physiological functions. We are reporting the first VMD investigation of the aggregation process of selected proteins, such as hydrophobic lectin nanoparticles, with potentially important applications in Nanomedicine for the prognosis and possibly therapy as well of cancers and Alzheimer's Disease (AD). In the case of AD there is a large body of accumulated evidence that hydrophobic aggregation of modified proteins such as the (or tau-) and beta-amyloid (or a-) abeta proteins may actually be the cause of AD. Any attempt at treatment of AD is however impeded by a lack of understanding of the highly complex interactions involved in the initiation and progression of AD, although-in the very rare cases of AD with a hereditary component-progress has been made through detailed genetic population models aided by computer statistical analysis. VMD has not been employed so far to unravel the very difficult complexity problems posed by the aggregation of hydrophobic proteins. As discussed in this report, the lectin plant proteins present both a useful model for studying hydrophobic nanoparticle aggregation and a possible approach to improving the prognosis and outcomes of AD as well as certain types of cancers not yet investigated through clinical trials.
Therefore, VMD applications in Nanomedicine have the potential for aiding the design and implementation of successful clinical trials in cancer and AD.
LECTIN APPLICATIONS TO CANCER DETECTION AND TREATMENT
Lectins are proteins, or more precisely glycoproteins, that agglutinate erythrocytes of some or all blood groups in vitro (Sharon 1998) . They are an important group of bioactive proteins and glycoproteins found in most organisms (Baianu and Prisecaru, 2011) , including plants, vertebrates, invertebrates, bacteria and viruses, and have several important applications to the fields of health food and medical biotechnology. Lectins are used as tools in the fields of biochemistry, cell biology and immunology, as well as for diagnostic and therapeutic purposes in cancer research (Sharon and Lis 2002) . Lectin aggregation can be employed on a large-scale basis for the commercial production of biologically active proteins (Takamatsu et al, 1999) .
Lectins have been used in glycoprotein purification, oligosaccharide analysis, as well as in cellselection processes. Lectins can bind reversibly with free sugars or with sugar residues of polysaccharides, glycoproteins or glycolipids (Goldstein and Poretz, 1986 ). There has been increasing demand for novel diagnostic and medical cancer therapies that utilize non-traditional sources. Epidemiological studies indicate that the consumption of a plant-based diet is strongly associated with a reduced risk of developing several types of cancer (Block et al, 1992) . Plants contain numerous phytochemicals that can alter cancer-associated biochemical pathways. One such group that was investigated examined for its role in cancer chemoprevention is lectins.
Lectins were reported to bind preferentially to cancer cell membranes, or their receptors, causing cytotoxicity, apoptosis and/or tumor growth inhibition. Lectins were thought to become internalized into cells, and some lectins were claimed to cause cancer cell agglutination and/or aggregation. Present in common foods, some lectins resist acid and/or enzymatic digestion and also were reported to enter the bloodstream in an intact, and biologically active, form. Lectins possess a spectrum of beneficial, as well as harmful, effects both in vitro and in vivo. Ingestion of lectins also sequesters the available body pool of polyamines, thereby claimed to thwart cancer cell growth. They have also been reported to affect the immune system by altering the production of various interleukins, or by activating certain protein kinases. Lectins were also reported to bind to ribosomes and thus inhibit protein synthesis. Lectins may also modify the cell cycle by inducing non-apoptotic G 1 -phase accumulation mechanisms, G 2 /M phase cell cycle arrest, and apoptosis, and might activate the caspase cascade. Lectins were also reported to down-regulate telomerase activity and inhibit angiogenesis. Lectins could inhibit cell adhesion, proliferation, colony formation and hemagglutination, and were reported to have cytotoxic effects on human tumor cells. Lectins could function as surface markers for tumor cell recognition, cell adhesion, signal transduction across the membrane, mitogenic cytotoxicity and apoptosis. Also, lectins were reported to modulate the growth, proliferation and apoptosis of premalignant and malignant cells both in vitro and in vivo. One important feature appears to be that lectins stimulate the human immune system. Lectins were thus reported to exhibit antitumor and anticarcinogenic activities that could be of substantial benefit in cancer treatment. Extracts of Viscum album (mistletoe) are widely used as complementary cancer therapies in Europe. Mistletoe has been used parenterally for more than 80 years as an anticancer agent with strong immuno-modulating action. The quality of life of patients with late-stage pancreatic cancer was reported to be improved on account of exposure to mistletoe lectin (Friess et al, 1996) . Immuno-modulation using recombinant ML was reported to influence tumor growth in breast cancer patients (Stein et al, 1998). Bladder carcinoma was reported to be significantly reduced, and survival times were reported to be prolonged in mice as the concentration of ML was increased from 3 to 30 ng. ML increased the life span, decreased the tumor growth and decreased hyperplasia of mice and rats with lymphoma and lung cancer Lectins have already a demonstrated potential for the treatment, prevention and diagnosis of chronic diseases such as cancer. However, further research is required to elucidate the effects of purified and dietary lectins and their potential for defense against tumors.
COMPUTATIONAL BIOLOGY, MOLECULAR MODELING AND THEIR

BIOMEDICAL APPLICATIONS IN NANOMEDICINE
Computational Biology has a very wide range of applications currently thought of 'belonging' to Biotechnology (Baianu, 1986) and Bioinformatics , even though the development of such computations has preceded modern Biotechnology by many decades.
Our approach is to focus on a few selected examples in greater depth, by considering molecular modeling techniques that have very wide applications, ranging from 'pure' chemistry to Biochemistry, Molecular Biology, Biotechnology, Nanomedicine, Pharmacology and Pharmacogenomics.
Molecular Modeling Techniques
Molecular modeling is a group of techniques that employ computer-generated images of chemical structures that show the relative positioning of all the atoms present in the molecule being studied, and/or the simulated dynamics of such molecules together with their ordering through space-time. Such techniques are of considerable help for understanding many physicochemical properties of molecules, and may also provide clues about their possible role(s), that is, their function, in the organism. They can be thus especially valuable tools for investigating structure-function relationships. Proteins --within a given protein family--have, in theory, similar sequences and generally share the same basic structure. Thus, once the structure for one member of the protein family is determined, molecular modeling computations can help determine the structure for other members of the same protein family. Such a homology technique when applied to protein structure may allow scientists to gain additional insight into protein structure, especially for those proteins for which the available experimental data is scarce.
Tasks in Molecular Modeling
In order to obtain optimal results, the National Center by Biotechnology (NCBI) suggested that protein sequences should be organized in protein families. Such readily searchable databases (Table 4) Secondly, a target must be selected. A target is a protein structure that has been determined via experiments. Thirdly, one must generate a purified protein for analysis of the chosen target and then determine the protein structure by analytical techniques such as X-ray crystallography and/or 2D-FT NMR.
The experiments described next, for example, studied apolipoprotein A-1 by employing molecular modeling techniques in order to understand the interaction of proteins in food systems and complex organisms.
Apolipoprotein Structures
Lipoprotein in mammals have evolved as the primary transport vehicles for lipids. This role leads to the importance of lipoproteins in several diseases, such as atherosclerosis and cardiovascular disease. Lipoprotein particles consist of a core of neutral lipids, stabilized by a surface monolayer of polar lipids complexed with one or more proteins.
Apolipoprotein A-I and apo B are respectively, the major protein components of high-density (HDL) and very low density (VLDL) lipoproteins. Thus, understanding apolipoproteins is very important for medical and health-related fields, such as medical biotechnology, as well as food science and human nutrition.
Methods of Structure Determination applied to Apolipoprotein Molecules
The process of biosynthesis, the physical characteristics and the metabolism of apolipoproteins have been intensely studied. However, because of the non-crystalline, or paracrystalline structure of many apolipoproteins (Baianu, 2012) , it has been difficult to obtain structural data at the molecular, or atomic level.
Therefore, methods combining the amino acid sequence with molecular methods are now being introduced. Thus, overall structures may be derived from correlations of global secondary structures determined from polarized light studies combined with local structures predicted from amino acid sequences. The known amino acid sequence of apolipoprotein from the position 7 to 156 of apo Lp-III was first used to design an Apo A-I template, that could be then approached by 'standard' molecular modeling techniques.
Molecular Modeling of Apolipoproteins A-I
Target: Apolipoprophorin III is chosen as a target for apolipoprotein A-I.(apo Lp A-I) .
The structure of Apolipophorin III has been determined in a crystal at 2. Table 5 . function of small, non-ionic side chain and serves as a helix-stabilizing residue. Although it has a high probability of being found in helical structures, it does not participate through electrostatic interactions. Results of this model are discussed for potential energetic evaluation and amphipathic analysis of energy refined helices (see Table 6 and Table 7 ). The structure obtained through this molecular modeling is illustrated in Figure 6 . kcal/mol/residueThese energy calculations, based on the sequence segments initially assigned to HI -H5 (see Tables 6 and 7) , are given to illustrate the stability of the structures. Sequences for helices 3 to 5 (H3, H4, H5) of apo Lp-IIIa contain inserted alanine residues. (Source: Brown, 1994). Table 7 . The size of the hydrophobic (Hb) sector of a helix was determined from helical Wheel projections (Schiffer et al 1967) The average hydrophobicity (Av. Hb), of this sector was calculated by the method of Eisenberg (1984) . Single letter designations are used for Amino acid residues, (al21d) designates the fourth alanine residue inserted between residues 121 and 122 of Lp-III. (Source: Brown, 1994 ).
After evaluating the potential energy for this model, the lateral view structures of apolipoproteins for apo lipophorin III(residues 7-156), canine apolipoptrotein A-I (residues 72-236), human apolipoprotein A-I (residues 73-237) and chicken apolipoprotein A-I (residues 72-236).
The computation results are shown in Figure 7 (according to Brown, 1994) . 
In-Depth Analyses of Molecular Structure
The 
Other Applications of Molecular Modeling
Other applications of molecular modeling to pharmacology, manufacturing, life sciences and chemistry greatly benefit from such molecular modeling programs. Nanotechnology has developed to a 30 to 40 million US $ market, and it also has the potential to grow to a 60 to 70 million US $ market within the next five years (Fuji-Keizai, 2003). 
CONCLUSIONS
A summary and simplified overview of the selected applications of nanotechnology in the areas of Nanomedicine, foods, human nutrition and health-as well as the potential large-scale applications in the chemical industry-that were discussed in this report is presented in Table 8 . The rapid development of biotechnological tools and 'quick' applications oriented towards immediate marketing may be responsible for generating legislative barriers against 'GMO-based' products. The complementary area of genetically manipulated microorganisms is adopting novel approaches to overcome such increasingly unprofitable legislative barriers and boost profits both in the short-and long-term.
The use of ultra-sensitive techniques and biocomputational modeling is essential in order to quantitate the physical and chemical properties of molecules and supra-molecular systems that are of primary interest to developments in nanotechnology and its applications to Nanomedicine.
